| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
General Counsel
1 company
Miller Edward is a General Counsel at Kalaris Therapeutics, Inc.. Recent SEC Form 4 filings include 0 buys and 4 sells.
Estimated insider holdings value: $31K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov 14, 2022 | KLRS Kalaris Therapeutics, Inc. | General Counsel | Sell | 2,358 | $8.91 | $21,018.03 | -1.2% | -26.1% | -81.2% | |
| Oct 19, 2022 | KLRS Kalaris Therapeutics, Inc. | General Counsel | Sell | 553 | $9.36 | $5,176.47 | -0.2% | -40.8% | -83.6% | |
| Mar 1, 2021 | KLRS Kalaris Therapeutics, Inc. | General Counsel | Sell | 6,000 | $38.78 | $232,699.40 | -1.5% | - | - |